Article

Choice of Ventricular Pacing Site: the End of Non-physiological, Apical Ventricular Pacing?

Disclosure: The author has no conflict of interest to declare.

Received:

Accepted:

Citation:Arrhythmia & Electrophysiology Review 2017;6(4):159–60.

Correspondence: Demosthenes G Katritsis, Hygeia Hospital, Erithrou Stavrous 4, Athens 15123, Greece. E: dkatrits@dgkatritsis.gr

Open access:

The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.

The ideal pacing site in the ventricle(s) of patients with atrioventricular (AV) block has been debated for years. Despite considerable technological advances, the optimal ventricular pacing site to mimic normal human ventricular physiology and attain the best haemodynamic response remains elusive.1

Prolonged ventricular dyssynchrony induced by long-term right ventricular (RV) apical pacing is associated with deleterious left ventricular (LV) remodelling and the deterioration of both LV diastolic and systolic function.2–4 The adverse effects of long-term RV apical pacing has led to tremendous interest in alternate pacing options. RV septal pacing sites are probably beneficial by means of intraventrcular synchrony and LV function5,6 and specific His-bundle pacing is a promising option, with acute results comparable to these of cardiac resynchronisation therapy.1,7,8 Biventricular pacing may also be superior,9 especially in patients with reduced LV ejection fraction. In the Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK-HF) trial, biventricular was preferable to RV pacing in the presence of LV ejection fraction <50 % and AV block, but the potential for increased LV lead-related complications should be considered.10 Interestingly, in crossover comparisons His-bundle pacing has been demonstrated to effect an equivalent cardiac resynchronisation pacing response, because it generates truly physiological ventricular activation, as evidenced in part by the identical morphology between normally-conducted and -paced QRS complexes.8

Theoretically, therefore, a mid-septal position should be the optimum site, at least in patients without a previous anteroseptal myocardial infarction. Why, then, has no benefit over apical pacing been definitively shown in randomised, comparative studies?11,12 There are reasons to believe that the main problem with these trials is their relatively limited follow-up times. Deleterious apical pacing takes years to express its adverse effects on ventricular remodelling and follow-up periods of <10 years may not be indicative. In the same manner, tachycardia-induced cardiomyopathies need several years to express their adverse impact on ventricular function.13

Figure 1: Mapping of Ventricular Electrical Activation

Article image

There is a need to avoid unnecessary apical RV pacing in patients with normal intrinsic AV conduction or intermittent AV block, especially in those at risk for heart failure. If we attempt to imitate nature through artificial pacing, we should get as close as possible to the normal conduction pathway in the ventricles, by targeting the His bundle. My personal view is that we certainly need randomised trials with a reasonably prolonged follow-up to explore this important issue. This might put the death-stone on the concept of non-physiological, apical ventricular pacing.

References

  1. Vijayaraman P, Bordachar P, Ellenbogen KA. The continued search for physiological pacing. Where are we now? J Am Coll Cardiol 2017;69:3099–114.
    Crossref | PubMed
  2. Fang F, Zhang Q, Chan JY, et al. Deleterious effect of right ventricular apical pacing on left ventricular diastolic function and the impact of pre-existing diastolic disease. Eur Heart J 2011;32:1891–9.
    Crossref | PubMed
  3. Zhang XH, Chen H, Siu CW, et al. New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function. J Cardiovasc Electrophysiol 2008;19:136–41.
    Crossref | PubMed
  4. Cicchitti V, Radico F, Bianco F, et al. Heart failure due to right ventricular apical pacing: the importance of flow patterns. Europace 2016;18:1679–88.
    Crossref | PubMed
  5. Shimony A, Eisenberg MJ, Filion KB, Amit G. Beneficial effects of right ventricular non-apical vs. apical pacing: a systematic review and meta-analysis of randomized-controlled trials. Europace 2012;14:81–91.
    Crossref | PubMed
  6. Weizong W, Zhongsu W, Yujiao Z, et al. Effects of right ventricular nonapical pacing on cardiac function: a meta-analysis of randomized controlled trials. Pacing Clin Electrophysiol 2013;36:1032–51.
    Crossref | PubMed
  7. Sharma PS, Dandamudi G, Naperkowski A, et al. Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice. Heart Rhythm 2015;12:305–12.
    Crossref | PubMed
  8. Lustgarten DL, Crespo EM, Arkhipova-Jenkins I, et al. His-bundle pacing versus biventricular pacing in cardiac resynchronization therapy patients: A crossover design comparison. Heart Rhythm 2015;12:1548–57.
    Crossref | PubMed
  9. Chan JY, Fang F, Zhang F, et al. Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur Heart J 2011;32:2533–40.
    Crossref | PubMed
  10. Curtis AB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 2013;368:1585–93.
    Crossref | PubMed
  11. Janousek J, van Geldorp IE, Krupicˇková S, et al. Working Group for Cardiac Dysrhythmias and Electrophysiology of the Association for European Pediatric Cardiology. Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study. Circulation 2013;127:613–23.
    Crossref | PubMed
  12. Kaye GC, Linker NJ, Marewick T, et al. Protect-Pace Trial Investigators. Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the Protect-Pace study. Eur Heart J 2015;36:856–62.
    Crossref | PubMed
  13. Ellis ER, Josephson ME. What about tachycardia-induced cardiomyopathy? Arrhythm Electrophysiol Rev 2013;2:82–90.
    Crossref | PubMed